Drugs that contain Trifarotene
1. Drug name - AKLIEF
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7807708 | GALDERMA LABS LP | Ligands that modulate RAR receptors and pharmaceutical/cosmetic compositions comprised thereof |
Oct, 2026
(3 years from now) | |
| CN101087752B | GALDERMA LABS LP | New Ligand Of Adjusting Rar Receptor And Use Thereof In Human Medicine And Cosmetics |
Dec, 2025
(3 years from now) | |
| CN101087752A | GALDERMA LABS LP | New Ligand Of Adjusting Rar Receptor And The Usage In The Human Medicine And Makeup Thereof |
Dec, 2025
(3 years from now) | |
| IN200705201P1 | GALDERMA LABS LP | Novel Ligands That Modulate Rar Receptors And Use Thereof Inhuman Medicine And In Cosmetics |
Dec, 2025
(3 years from now) | |
| IN284413B | GALDERMA LABS LP | Novel Ligands That Modulate Rar Receptors And Use Thereof In Human Medicine And In Cosmetics |
Dec, 2025
(3 years from now) | |
| EP1831149B1 | GALDERMA LABS LP | Novel Ligands That Modulate Rar Receptors And Use Thereof In Human Medicine And In Cosmetics |
Dec, 2025
(3 years from now) | |
| EP1831149A1 | GALDERMA LABS LP | Novel Ligands That Modulate Rar Receptors And Use Thereof In Human Medicine And In Cosmetics |
Dec, 2025
(3 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8470871 | GALDERMA LABS LP | Ligands that modulate RAR receptors |
Dec, 2025
(3 years from now) | |
| US8227507 | GALDERMA LABS LP | Ligands that modulate RAR receptors |
Dec, 2025
(3 years from now) | |
| US9084778 | GALDERMA LABS LP | Topical compositions containing a retinoid of the oil-in-water emulsion type |
May, 2033
(10 years from now) | |
| US9498465 | GALDERMA LABS LP | Topical compositions in the form of a gel containing a particular solubilized retinoid |
May, 2033
(10 years from now) | |
Treatment: Method of activating rargamma receptor; Topical treatment of acne vulgaris; Treatment of acne vulgaris
Dosage: CREAM;TOPICAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.005% | CREAM;TOPICAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.